
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs - 2
A photographer's journey to capture a blood moon rising over the South China Sea. 'It was an incredible moment' - 3
Very good quality Greens All over The Planet - 4
What to watch for as NASA’s historic Artemis II crew prepares to lift off toward the moon - 5
Russia Fields New Ulan-2 All-Terrain Tactical Vehicle
Hilary Duff's husband responds to Ashley Tisdale's 'toxic' mom group claims: The drama, explained
Australians told to continue Easter travel plans despite fuel shortages
Experience Unrivaled Sound: Top Speakers You Really want to Hear
Nurturing Hacks: Astuteness from Experienced Mothers and Fathers
Figure out How to Really focus on Your Dental Inserts for Durable Outcomes
Exploring the Gig Economy: Illustrations from Consultants
Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers
'Senseless violence' erupts at Christmas tree lighting; 4 injured
Italian police hold suspected boss of Naples Mafia's Mazzarella Clan












